Related Experiment Video
Updated: Apr 26, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Inhibitory control dysfunction in nicotine dependence and the influence of short-term abstinence
Kathleen Charles-Walsh1, Liam Furlong1, David G Munro1
1Melbourne School of Psychological Sciences, University of Melbourne, Parkville, Melbourne 3010, VIC, Australia.
Background:
Although the majority of substance use disorders depict reliable deficits in inhibitory control (IC), similar deficits are not consistently found in nicotine dependence. The mixed results of past research may have been due to confounding variables known to independently influence IC function, including age, concurrent drug use and particularly, length of nicotine abstinence.
Methods:
A stop signal task was used to examine stop signal reaction time (SSRT), a typical measure of IC, in nicotine dependence across two studies that attempted to closely control for IC confounds. Study 1 compared the SSRT of 37 dependent cigarette smokers (11 females) to 36 non-smokers (13 females), following 3-h of nicotine abstinence. Study 2 compared 22 dependent cigarette smokers' (11 females) SSRT scores when satiated on nicotine to their performance following 10-h of nicotine abstinence.
Results:
Nicotine dependent individuals did not differ from controls in SSRT performance following 3-h abstinence, but showed a significant decline in performance following 10-h abstinence, when compared to nicotine satiation.
Conclusions:
During shorter abstinence periods, the acute benefits of nicotine satiation appear to facilitate inhibitory control; however, IC was poorer during extended periods of nicotine abstinence. In turn, this suggests that the reliability of IC dysfunction in nicotine dependence varies according to abstinence length and needs to be carefully considered for future behavioural and neuroimaging examination of IC within this population.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena

